Aim: To describe the broad clinical spectrum of ataxia with oculomotor apraxia type 2 (AOA2) in two cases.
mutations of the senataxin gene (9q34). Clinical spectrum comprises neuropathy, oculomotor apraxia, gait ataxia and choreatic or dystonic movements. First symptoms are usually noticed between the age of 10 and 25 years. Alpha-fetoprotein (AFP) is nearly always elevated.
Methods: Case 1 is a 56-year old female with disease onset around 35 years who came to medical attention with involuntary head movements which were interpreted as cervical dystonia. At that time, a CT scan of the brain was normal. After another 10 years she was referred due to progressive gait difficulties and problems with her eyes, which had developed over the past years. Clinical examination revealed gait ataxia and oculomotor apraxia and an MRI showed cerebellar atrophy.
Case 2 is a 35-year old man who was referred for mild gait ataxia. In childhood and early adulthood he experienced difficulties in doing sports. Dysarthria and gait ataxia developed in the third decade and remained mild until presentation.
A DAT-scan was normal and MRI showed marked cerebellar atrophy. Conclusion: These two cases highlight the broad clinical spectrum of AOA2.
While patient 2 represents a case of young onset cerebellar ataxia without ocular apraxia patient 1 with a novel missense mutation in the senataxin gene has a late disease onset far beyond 30 years with cerebellar ataxia, dystonia
